Archive
Latest news
The Worlds first clinical human study on anthocyanins and its effect on Chronic Inflammation
The study concludes: ” These data suggest that anthocyanin supplementation (Medox®) may have a role in prevention or treatment of chronic inflammatory diseases by inhibition of NF-KappaB transactivation and deceased plasma concentration of pro-inflammatory chemokines, cytokines, and inflammatory mediators. R. Blomhoff et al, Journal of Nutrition, August 2007, USA.
-
Cardiovascular study on Medox and cholesterol and CETP
A human, randomized, double blind, placebo controlled study done was at one of Chinas 10 leading research universities (China has 1.200 universities). The study had been worked on for 3 years and showed that Medox modulates the cholesterol (Increase HDL and lower LDL) significantly (close to 30%).
-
Multiple effects of anthocyanins inhibiting influenza (flu) virus infectivity
Multiple effects of anthocyanins inhibiting influenza (flu) virus infectivity, decreasing secondary tissue damage and boosting the immune system: How important are anthocyanins in human ability to fight viral infections?
-
Anthocyanins Inhibit Nuclear Factor- B
Anthocyanins Inhibit Nuclear Factor- B Activation in Monocytes and Reduce Plasma Concentrations of Pro-Inflammatory Mediators in Healthy Adults.
-
New clinical, human cardiovascular study on Medox®
-
Possible effect on hypertension
Study on Biolinks synthetic anthocyanin molecules BSC-3-GPS and BSD-3-GPS and possible effect on hypertension in rats starts at the Ullevål University Hospital (UUS).
-
Protective against myelotoxicity
Study based on anthocyanin standards from Biolink Group, finds “Protective effect of anthocyanin-rich extract from bilberry against myelotoxicity induced by 5-fluorouracil".
-
Anthocyanins and their effect on Chronic Inflammation
The Worlds first clinical human study on anthocyanins and their effect on Chronic Inflammation based on the Biolink nutrition supplement Medox®.
-
Prevent CD40-Activated Proinflammatory Signaling
Researchers at Sun Yat-sen University, Guangzhou, Peoples Republic of China, finds that Biolink anthocyanins; Prevent CD40-Activated Proinflammatory Signaling in Endothelial Cells by Regulating Cholesterol Distribution.
-
The Metabolic Syndrome
Clinical study on Medox® and its influence on The Metabolic Syndrome, started in Sun Yat-sen University, Guangzhou, Peoples Republic of China.